Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

In today’s data-rich environment, business are always looking for a way to capitalize on available data for new insights and increased efficiencies. Given the escalating volumes of data and the ...

If you’re new to Python, one of the first things you’ll encounter is variables and data types. Understanding how Python handles data is essential for writing clean, efficient, and bug-free programs.

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

What if the tools you already use could do more than you ever imagined? Picture this: you’re working on a massive dataset in Excel, trying to make sense of endless rows and columns. It’s slow, ...

If you’ve ever found yourself staring at a messy spreadsheet of survey data, wondering how to make sense of it all, you’re not alone. From split headers to inconsistent blanks, the challenges of ...

Structure Therapeutics' stock has declined over 40% since last year, but its differentiated technology platform and promising drug pipeline still support a "Buy" rating. Structure's lead candidate, ...